These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28388560)

  • 1. GALNT6 expression enhances aggressive phenotypes of ovarian cancer cells by regulating EGFR activity.
    Lin TC; Chen ST; Huang MC; Huang J; Hsu CL; Juan HF; Lin HH; Chen CH
    Oncotarget; 2017 Jun; 8(26):42588-42601. PubMed ID: 28388560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
    Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
    Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GALNT6 Stabilizes GRP78 Protein by O-glycosylation and Enhances its Activity to Suppress Apoptosis Under Stress Condition.
    Lin J; Chung S; Ueda K; Matsuda K; Nakamura Y; Park JH
    Neoplasia; 2017 Jan; 19(1):43-53. PubMed ID: 28110670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
    Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
    Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylgalactosaminyltransferase GALNT6 is a potential therapeutic target of clear cell renal cell carcinoma progression.
    Sun L; Li Z; Shu P; Lu M
    Cancer Sci; 2024 Oct; 115(10):3320-3332. PubMed ID: 39105355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GALNT6 promotes breast cancer metastasis by increasing mucin-type O-glycosylation of α2M.
    Liu C; Li Z; Xu L; Shi Y; Zhang X; Shi S; Hou K; Fan Y; Li C; Wang X; Zhou L; Liu Y; Qu X; Che X
    Aging (Albany NY); 2020 Jun; 12(12):11794-11811. PubMed ID: 32559179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological Changes, Cadherin Switching, and Growth Suppression in Pancreatic Cancer by GALNT6 Knockdown.
    Tarhan YE; Kato T; Jang M; Haga Y; Ueda K; Nakamura Y; Park JH
    Neoplasia; 2016 May; 18(5):265-272. PubMed ID: 27237318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
    Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
    Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
    Wu YM; Liu CH; Hu RH; Huang MJ; Lee JJ; Chen CH; Huang J; Lai HS; Lee PH; Hsu WM; Huang HC; Huang MC
    Cancer Res; 2011 Dec; 71(23):7270-9. PubMed ID: 21990321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX3-Regulated GALNT6 Promotes the Migration and Invasion of Hepatocellular Carcinoma Cells by Mediating O-Glycosylation of MUC1.
    Gao F; Zheng G
    Dis Markers; 2022; 2022():2959846. PubMed ID: 35909886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression.
    Sheta R; Bachvarova M; Macdonald E; Gobeil S; Vanderhyden B; Bachvarov D
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31071912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13.
    Wang R; Yu C; Zhao D; Wu M; Yang Z
    Oncol Rep; 2013 Aug; 30(2):667-76. PubMed ID: 23708057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
    Park JH; Katagiri T; Chung S; Kijima K; Nakamura Y
    Neoplasia; 2011 Apr; 13(4):320-6. PubMed ID: 21472136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosyltransferase Gene Expression Identifies a Poor Prognostic Colorectal Cancer Subtype Associated with Mismatch Repair Deficiency and Incomplete Glycan Synthesis.
    Noda M; Okayama H; Tachibana K; Sakamoto W; Saito K; Thar Min AK; Ashizawa M; Nakajima T; Aoto K; Momma T; Katakura K; Ohki S; Kono K
    Clin Cancer Res; 2018 Sep; 24(18):4468-4481. PubMed ID: 29844132
    [No Abstract]   [Full Text] [Related]  

  • 15. Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling.
    Huang MJ; Hu RH; Chou CH; Hsu CL; Liu YW; Huang J; Hung JS; Lai IR; Juan HF; Yu SL; Wu YM; Huang MC
    Oncotarget; 2015 Mar; 6(8):5650-65. PubMed ID: 25730904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.
    Chen CH; Wang SW; Chen CW; Huang MR; Hung JS; Huang HC; Lin HH; Chen RJ; Shyu MK; Huang MC
    Gynecol Oncol; 2013 Mar; 128(3):560-7. PubMed ID: 23262208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GALNT6 promotes invasion and metastasis of human lung adenocarcinoma cells through O-glycosylating chaperone protein GRP78.
    Song J; Liu W; Wang J; Hao J; Wang Y; You X; Du X; Zhou Y; Ben J; Zhang X; Ye M; Wang Q
    Cell Death Dis; 2020 May; 11(5):352. PubMed ID: 32393740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypeptide
    Guo Y; Shi J; Zhang J; Li H; Liu B; Guo H
    Onco Targets Ther; 2017; 10():3337-3344. PubMed ID: 28744137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of erlotinib and a PARP inhibitor inhibits growth of A2780 tumor xenografts due to increased autophagy.
    Sui H; Shi C; Yan Z; Li H
    Drug Des Devel Ther; 2015; 9():3183-90. PubMed ID: 26124641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.